Normal view MARC view ISBD view

p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes.

Menon, Ramkumar

p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes. [electronic resource] - Expert opinion on therapeutic targets Dec 2016 - 1397-1412 p. digital

Publication Type: Journal Article; Review

ISSN: 1744-7631

Standard No.: 10.1080/14728222.2016.1216980 doi

Subjects--Topical Terms:
Animals
Female
Fetal Membranes, Premature Rupture--prevention & control
Humans
Oxidative Stress--physiology
Pregnancy
Pregnancy Outcome
Premature Birth--prevention & control
Risk Factors
Telomere--metabolism
p38 Mitogen-Activated Protein Kinases--metabolism

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)